| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |